Search research articles
Contact Us
Filters
Showing results (331-340 of 441) with videos related to
Page
of 45
Sort By:
Journal of Hepatology
|
December 15, 2010
Potency, safety, and pharmacokinetics of the NS3/4A protease inhibitor BI201335 in patients with chronic HCV genotype-1 infection
Michael P Manns, Marc Bourlière, Yves Benhamou, et al.
Advances in Therapy
|
May 22, 2021
Safety of Patients with Hepatitis C Virus Treated with Glecaprevir/Pibrentasvir from Clinical Trials and Real-World Cohorts
Xavier Forns, Jordan J Feld, Douglas E Dylla, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
November 12, 2024
Direct Antivirals Can Achieve a Cure in All Patients With Chronic Hepatitis C due to Genotype 5: A French Multicentre Study
Carine Nicolas, Quentin Domas, Stanislas Pol, et al.
Journal of Hepatology
|
October 4, 2021
Burden of liver disease progression in hospitalized patients with type 2 diabetes mellitus
Vincent Mallet, Lucia Parlati, Alessandro Martinino, et al.
Clinical and Experimental Gastroenterology
|
December 7, 2016
HCVerso1 and 2: faldaprevir with deleobuvir (BI 207127) and ribavirin for treatment-naïve patients with chronic hepatitis C virus genotype-1b infection
Christoph Sarrazin, Francesco Castelli, Pietro Andreone, et al.
The New England Journal of Medicine
|
May 1, 2009
Telaprevir and peginterferon with or without ribavirin for chronic HCV infection
Christophe Hézode, Nicole Forestier, Geoffrey Dusheiko, et al.
Hepatology (Baltimore, Md.)
|
March 19, 2013
Faldaprevir combined with peginterferon alfa-2a and ribavirin in chronic hepatitis C virus genotype-1 patients with prior nonresponse: SILEN-C2 trial
Mark S Sulkowski, Marc Bourlière, Jean-Pierre Bronowicki, et al.
Gastroenterology
|
March 10, 2017
Direct-Acting Antiviral Therapy Restores Immune Tolerance to Patients With Hepatitis C Virus-Induced Cryoglobulinemia Vasculitis
Cloé Comarmond, Marlène Garrido, Stanislas Pol, et al.
Journal of Hepatology
|
January 17, 2013
Limited impact of IL28B genotype on response rates in telaprevir-treated patients with prior treatment failure
Stanislas Pol, Jeroen Aerssens, Stefan Zeuzem, et al.
Kidney International
|
November 21, 2022
Executive Summary of the KDIGO 2022 Clinical Practice Guideline for the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease
Paul Martin, Ahmed A Awan, Marina C Berenguer, et al.
Page
of 45
Search research articles
Search
Showing results (331-340 of 441) with videos related to
Sort By:
Page
of 45
Journal of Hepatology
|
December 15, 2010
Potency, safety, and pharmacokinetics of the NS3/4A protease inhibitor BI201335 in patients with chronic HCV genotype-1 infection
Michael P Manns, Marc Bourlière, Yves Benhamou, et al.
Advances in Therapy
|
May 22, 2021
Safety of Patients with Hepatitis C Virus Treated with Glecaprevir/Pibrentasvir from Clinical Trials and Real-World Cohorts
Xavier Forns, Jordan J Feld, Douglas E Dylla, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
November 12, 2024
Direct Antivirals Can Achieve a Cure in All Patients With Chronic Hepatitis C due to Genotype 5: A French Multicentre Study
Carine Nicolas, Quentin Domas, Stanislas Pol, et al.
Journal of Hepatology
|
October 4, 2021
Burden of liver disease progression in hospitalized patients with type 2 diabetes mellitus
Vincent Mallet, Lucia Parlati, Alessandro Martinino, et al.
Clinical and Experimental Gastroenterology
|
December 7, 2016
HCVerso1 and 2: faldaprevir with deleobuvir (BI 207127) and ribavirin for treatment-naïve patients with chronic hepatitis C virus genotype-1b infection
Christoph Sarrazin, Francesco Castelli, Pietro Andreone, et al.
The New England Journal of Medicine
|
May 1, 2009
Telaprevir and peginterferon with or without ribavirin for chronic HCV infection
Christophe Hézode, Nicole Forestier, Geoffrey Dusheiko, et al.
Hepatology (Baltimore, Md.)
|
March 19, 2013
Faldaprevir combined with peginterferon alfa-2a and ribavirin in chronic hepatitis C virus genotype-1 patients with prior nonresponse: SILEN-C2 trial
Mark S Sulkowski, Marc Bourlière, Jean-Pierre Bronowicki, et al.
Gastroenterology
|
March 10, 2017
Direct-Acting Antiviral Therapy Restores Immune Tolerance to Patients With Hepatitis C Virus-Induced Cryoglobulinemia Vasculitis
Cloé Comarmond, Marlène Garrido, Stanislas Pol, et al.
Journal of Hepatology
|
January 17, 2013
Limited impact of IL28B genotype on response rates in telaprevir-treated patients with prior treatment failure
Stanislas Pol, Jeroen Aerssens, Stefan Zeuzem, et al.
Kidney International
|
November 21, 2022
Executive Summary of the KDIGO 2022 Clinical Practice Guideline for the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease
Paul Martin, Ahmed A Awan, Marina C Berenguer, et al.
Page
of 45